Retour
Fourchette du Jour
72,47 €
75,70 €
Fourchette 52 Semaines
23,18 €
123,75 €
Volume
176 561
Moyenne 50J / 200J
81,08 €
/
58,29 €
Clôture Précédente
71,62 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -46,0 | 0,4 |
| P/B | 6,9 | 2,9 |
| ROE % | -27,9 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
136,50 €
+88.4%
Low: 126,00 €
High: 147,00 €
BPA Prévisionnel
-4,76 €
CA Est.
0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-4,82 €
-4,82 € – -4,82 €
|
110 M | 1 |
| FY2029 |
-7,41 €
-7,41 € – -7,41 €
|
110 M | 1 |
| FY2028 |
-9,50 €
-12,70 € – -5,66 €
|
36 M | 5 |
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-27,93%
ROIC-12,72%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio36,10
Interest Coverage0,00
Valorisation
P/E Ratio
-45,99
P/B Ratio6,86
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -12,23M |
| ROE | -27,93% | ROA | -14,49% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | -12,72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 36,10 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -45,99 | P/B Ratio | 6,86 |
| P/S Ratio | N/A | PEG Ratio | -0,27 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 562,48M | Enterprise Value | 479,69M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -12,23M | -2,80M | -7,37M | -14,96M | -8,65M |
| EPS (Diluted) | -1,78 | -0,65 | -1,98 | -6,15 | -4,74 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -13,94M | -2,82M | -7,39M | -14,98M | -8,62M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 84,42M | 6,10M | 6,88M | 12,09M | 20,04M |
| Total Liabilities | 2,38M | 568 259,0 | 280 856,0 | 1,54M | 638 573,0 |
| Shareholders' Equity | 82,04M | 5,54M | 6,60M | 10,54M | 19,40M |
| Total Debt | 125 777,0 | 118 960,0 | 73 549,0 | 139 911,0 | 0,0 |
| Cash & Equivalents | 82,91M | 5,72M | 6,75M | 11,63M | 19,76M |
| Current Assets | 84,31M | 5,99M | 6,81M | 11,95M | 20,04M |
| Current Liabilities | 2,34M | 528 683,0 | 280 856,0 | 1,47M | 638 573,0 |